Format

Send to

Choose Destination
See comment in PubMed Commons below
Rhinology. 2016 Jun;54(2):129-33. doi: 10.4193/Rhin15.072.

Stratification of SNOT-22 scores into mild, moderate or severe and relationship with other subjective instruments.

Author information

1
ENT Dept, Kennington Road, Willesborough, Ashford, Kent, United Kingdom.
2
ENT Dept, Guys and St Thomas Hospitals NHS Trust, London, United Kingdom.

Abstract

AIMS AND OBJECTIVES:

The European Position Paper on Rhinosinusitis and Nasal Polyps provides treatment algorithms based on the mild/moderate/severe (MMS) classification. To date there has been no statistically validated stratification of the SNOT-22 score according to this classification.

METHODS:

65 consecutive patients diagnosed with CRS completed a SNOT-22, VAS and rated their symptoms according to MMS and impact on quality of life.

RESULTS:

The median SNOT 22 scores varied between the 3 MMS categories. The interquartile ranges for the respective MMS groups were: Mild 8-17, Moderate 22.5-48, Severe 54-83. Median values for the respective MMs groups were: Mild 12, Moderate 36 and Severe 66. 15.38% of patients in the Mild category, 95.24% in the Moderate category and 100% in the Severe category feel their QoL is affected. There was a strongly positive correlation between the SNOT-22 and VAS scores.

CONCLUSION:

We propose a statistically validated definition for stratification of the SNOT-22, with Mild being defined on the SNOT-22 score as 8-20 inclusive, Moderate as >20-50 and Severe as >50.

PMID:
27017484
DOI:
10.4193/Rhin15.072
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for International Rhinologic Society
    Loading ...
    Support Center